Loading…
Phase 1/2 Trial of Durvalumab and Lenalidomide in Patients with Cutaneous T Cell Lymphoma (CTCL): Preliminary Results of Phase I Results and Correlative Studies
Querfeld, Christiane, Zain, Jasmine M., Wakefield, Devin L., Jovanovic-Talisman, Tijana, Kil, Sung Hee, Estephan, Renee, Sanchez, James, Palmer, Joycelynne, Rosen, Steven T
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Loading…
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer
Hinchcliff, Emily M., Knisely, Anne, Adjei, Naomi, Fellman, Bryan, Yuan, Ying, Patel, Ami, Xu, Cai, Westin, Shannon N., Sood, Anil K., Soliman, Pamela T., Shafer, Aaron, Fleming, Nicole D., Gershenson, David M., Vikram, Raghunandan, Bathala, Tharakeswara, Vining, David, Ganeshan, Dhakshina M., Lu, Karen H., Sun, Charlotte C., Meyer, Larissa A., Jazaeri, Amir A.
Published in Cancer (01.04.2024)
Published in Cancer (01.04.2024)
Get full text
Journal Article
Loading…
Combined treatment of durvalumab, bevacizumab and tremelimumab in subjects with hepatocellular carcinoma (HCC) or biliary tract carcinoma (BTC)
Awosika, Joy, Monge B., M. Cecilia, Xie, Changqing, Skorupan, Nebojsa, Kleiner, David E., Mabry Hrones, Donna, Wood, Brad, Redd, Bernadette, Greten, Tim F.
Published in Journal of clinical oncology (01.06.2025)
Published in Journal of clinical oncology (01.06.2025)
Get full text
Journal Article
Loading…
A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma
Patel, Shetal A., Gibson, Michael K., Deal, Allison, Sheth, Siddharth, Heiling, Hillary, Johnson, Steven M., Douglas, Kathe, Flores, Melissa, Blumberg, Jeffrey, Lumley, Catherine, Yarbrough, Wendell G., Shen, Colette, Chera, Bhishamjit S., Bauman, Jessica R., Hackman, Trevor, Weiss, Jared
Published in Cancer (01.11.2023)
Published in Cancer (01.11.2023)
Get full text
Journal Article
Loading…
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors
Naing, Aung, Algazi, Alain P., Falchook, Gerald S., Creelan, Benjamin C., Powderly, John, Rosen, Seth, Barve, Minal, Mettu, Niharika B., Triozzi, Pierre L., Hamm, John, Zhou, Gongfu, Walker, Chris, Dong, Zhiwan, Patel, Manish R.
Published in Cancer (01.01.2023)
Published in Cancer (01.01.2023)
Get full text
Journal Article
Loading…
A phase 2 study of durvalumab plus DOS (docetaxel, oxaliplatin, S-1) neoadjuvant chemotherapy followed by surgery and adjuvant durvalumab plus S-1 chemotherapy in patients with resectable locally advanced gastric cancer: An interim efficacy report
Kim, Hyung-Don, Ryu, Min-Hee, Park, Young Soo, Lee, Jong Seok, Kang, Yoon-Koo
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Loading…
A phase 1b/2, open-label study of tivozanib in combination with durvalumab in subjects with advanced hepatocellular carcinoma (Deductive)
Dayyani, Farshid, Lee, Arielle Shebay, Li, Daneng, Rowe, Julie Haewon, Beg, Muhammad Shaalan, Kasturi, Vijay, Iyer, Renuka V.
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Loading…
CTIM-32. PHASE I/II STUDY OF STEREOTACTIC RADIOSURGERY WITH CONCURRENT OLAPARIB FOLLOWED BY ADJUVANT DURVALUMAB AND PHYSICIAN’S CHOICE SYSTEMIC THERAPY IN SUBJECTS WITH BREAST CANCER BRAIN METASTASES (SOLARA)
Shen, Colette, Abdou, Yara, Chen, Linda, Tan, Xianming, Gupta, Gaorav, Lynce, Filipa, Lobbous, Mina, Stringer-Reasor, Erica, Anders, Carey
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2024)
Published in Neuro-oncology (Charlottesville, Va.) (11.11.2024)
Get full text
Journal Article
Loading…
937P Survival outcomes in phase I trial combining VCN-01 and durvalumab (MEDI4736) in subjects with recurrent/metastatic head and neck squamous cell carcinoma refractory to previous immunotherapy treatment
Jové, M., Braña, I., Oliva Bernal, M., Hernando Calvo, A., Erasun Lecuona, C., Assaf Pastrana, J.D., Mato-Berciano, A., Maliandi, M.V., Torres-Manjon, S., Moreno, R., Le, C., Nuciforo, P.G., Alemany, R., Capella, G., Blasco, C., Cascallo Piqueras, M., Mesia Nin, R.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Loading…
SUB-urothelial durvalumab injection: 1 (SUBDUE-1)-Results from the first nine urothelial cancer patients using a dose-escalation schedule
Hayne, Dickon, Swarbrick, Nicole, McCombie, Stephen, Moe, Andrew, Hawks, Cynthia, Viswambaram, Pravin, Conduit, Ciara, Liow, Elizabeth Chien Hern, Spalding, Lisa, Bothe, Jarrad, Ferguson, Tom, Martin, Andrew James, Davis, Ian D., Redfern, Andrew David
Published in Journal of clinical oncology (20.02.2022)
Published in Journal of clinical oncology (20.02.2022)
Get full text
Journal Article
Loading…
Quality of life (QoL) in patients with recurrent ovarian clear cell carcinoma (rOCCC) receiving durvalumab (D) versus physician's choice chemotherapy (PCC) in the randomized phase II MOCCA/APGOT-OV2/GCGS-OV3 trial
Sun, Haoyang, Choi, Chel Hun, Heong, Valerie, Ow, Samuel Guan Wei, Chay, Wen Yee, Kim, Hee Seung, Goss, Geraldine, Goh, Jeffrey C., Lin, Meiqi, Lim, Diana, Kim, Jae-Weon, Friedlander, Michael, Tai, Bee Choo, Kim, Kidong, Tan, David Shao Peng
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Loading…
DEDUCTIVE: A study of tivozanib in combination with durvalumab in subjects with untreated advanced hepatocellular carcinoma—Phase Ib results
Iyer, Renuka V., Li, Daneng, Dayyani, Farshid, Phan, Alexandria T., Needle, Michael N., Abrams, Thomas Adam
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Loading…
Phase 2 open label study of durvalumab with neoadjuvant chemotherapy in variant histology bladder cancer
Khaki, Ali Raza, Fan, Alice C., Shah, Sumit, Parikh, Divya Ahuja, Chien, Joanne, Moore, Kaidi, Ruiz, Shann Mika, Haas, Denise, Fakhoury, Laith, Del Toro, Noël, Baker, Paige, O'Brien, Aidan, Srinivas, Sandy
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Loading…
Phase 1b/2 study of tivozanib in combination with durvalumab in subjects with advanced hepatocellular carcinoma (Deductive): Efficacy results in previously untreated patients
Iyer, Renuka V., Li, Daneng, Dayyani, Farshid, Rowe, Julie Haewon, Beg, Muhammad Shaalan, Kasturi, Vijay, Abrams, Thomas Adam
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
Loading…
A phase Ib/II, open-label study of tivozanib in combination with durvalumab in subjects with untreated advanced hepatocellular carcinoma
Iyer, Renuka V., Li, Daneng, Dayyani, Farshid, Needle, Michael N., Abrams, Thomas Adam
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Loading…
CTIM-02. TIP: PHASE I/II STUDY OF STEREOTACTIC RADIOSURGERY WITH CONCURRENT OLAPARIB FOLLOWED BY ADJUVANT DURVALUMAB AND PHYSICIAN’S CHOICE SYSTEMIC THERAPY IN SUBJECTS WITH BREAST CANCER BRAIN METASTASES
Shen, Colette, Abdou, Yara, Tan, Xianming, Gupta, Gaorav, Lynce, Filipa, Stringer-Reasor, Erica, Anders, Carey
Published in Neuro-oncology (Charlottesville, Va.) (14.11.2022)
Published in Neuro-oncology (Charlottesville, Va.) (14.11.2022)
Get full text
Journal Article
Loading…
Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab
Delasos, Lukas, Wei, Wei, Hassan, Khaled A., Pennell, Nathan A., Patil, Pradnya, Stevenson, James
Published in Clinical lung cancer (01.09.2023)
Published in Clinical lung cancer (01.09.2023)
Get full text
Journal Article
Loading…
1231P Phase I study to evaluate the safety, tolerability, and efficacy of VCN-01 in combination with durvalumab (MEDI4736) in subjects with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC)
Jove, M., Brana, I., Oliva Bernal, M., Hernando-Calvo, A., Erasun Lecuona, C., Assaf Pastrana, J.D., Bazan Peregrino, M., Mato-Berciano, A., Maliandi, M.V., Torres-Manjon, S., Martinez de Villareal, J., Real, F.X., Nuciforo, P.G., Alemany, R., Capella, G., Blasi, E., Blasco, C., Cascallo Piqueras, M., Mesia Nin, R.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Loading…
Loading…
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Borghetti, Paolo, Imbrescia, Jessica, Volpi, Giulia, Scotti, Vieri, Aquilano, Michele, Bruni, Alessio, Franceschini, Davide, Ursino, Stefano, Ciammella, Patrizia, Piperno, Gaia, Taraborrelli, Maria, Magrini, Stefano Maria
Published in Radiation oncology (London, England) (16.07.2022)
Published in Radiation oncology (London, England) (16.07.2022)
Get full text
Journal Article